Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
ROBO Global Robotics & Automation Index ETF
ROBO
$2.12B
| $414K | ﹤0.01% |
7,100
+2,400
| +51% | +$146K |
|
3302
Dyne Therapeutics
DYN
$4.78B
| $412K | ﹤0.01% |
42,700
-25,800
| -38% | -$220K |
|
3303
Mega Matrix
MPU
$14.3M
| $411K | ﹤0.01% |
+205,700
| New | +$1.16M |
|
3304
Addus HomeCare
ADUS
$2.17B
| $410K | ﹤0.01% |
4,400
-8,000
| -65% | -$643K |
|
3305
Wave Life Sciences
WVE
$1.05B
| $410K | ﹤0.01% |
205,194
+167,894
| +450% | +$411K |
|
|
COWN
3306
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $410K | ﹤0.01% |
+15,128
| New | +$460K |
|
3307
Ribbon Communications
RBBN
$374M
| $409K | ﹤0.01% |
132,411
+74,011
| +127% | +$303K |
|
3308
Amerant Bancorp
AMTB
$1.14B
| $407K | ﹤0.01% |
12,880
-2,418
| -16% | -$80.1K |
|
3309
Gray Media Inc
GTN.A
| $407K | ﹤0.01% |
19,800
-400
| -2% | -$8.26K |
|
3310
Scholastic
SCHL
$785M
| $407K | ﹤0.01% |
+10,100
| New | +$418K |
|
3311
Broadway Financial
BYFC
$114M
| $406K | ﹤0.01% |
31,892
+9,679
| +44% | +$141K |
|
3312
MasterCraft Boat Holdings
MCFT
$590M
| $406K | ﹤0.01% |
16,500
+6,600
| +67% | +$175K |
|
3313
Cabaletta Bio
CABA
$442M
| $405K | ﹤0.01% |
+199,400
| New | +$521K |
|
3314
Equinox Gold
EQX
$13.6B
| $405K | ﹤0.01% |
+49,000
| New | +$345K |
|
3315
Pennant Group
PNTG
$1.36B
| $405K | ﹤0.01% |
21,761
-16,439
| -43% | -$274K |
|
3316
Sharplink Inc
SBET
$1.35B
| $405K | ﹤0.01% |
2,350
-53
| -2% | -$10.6K |
|
|
SGTX
3317
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| $405K | ﹤0.01% |
21,200
+12,053
| +132% | +$269K |
|
|
MOFG
3318
DELISTED
MidWestOne Financial Group
MOFG
| $404K | ﹤0.01% |
12,200
-2,700
| -18% | -$86.3K |
|
|
NBSE
3319
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $404K | ﹤0.01% |
10,742
+4,623
| +76% | +$160K |
|
|
KAMN
3320
DELISTED
Kaman Corp
KAMN
| $404K | ﹤0.01% |
+9,300
| New | +$394K |
|
|
STRM
3321
DELISTED
Streamline Health Solutions
STRM
| $403K | ﹤0.01% |
16,778
-367
| -2% | -$7.86K |
|
3322
ProShares UltraPro Short 20+ Year Treasury
TTT
$18.8M
| $403K | ﹤0.01% |
+9,900
| New | +$368K |
|
3323
MediciNova
MNOV
$64.5M
| $400K | ﹤0.01% |
149,700
+7,400
| +5% | +$18.1K |
|
3324
Armata Pharmaceuticals
ARMP
$167M
| $399K | ﹤0.01% |
81,696
-3,100
| -4% | -$15.9K |
|
|
SALM
3325
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $399K | ﹤0.01% |
117,700
-116,863
| -50% | -$400K |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 822 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.